Clinical Trials Directory

Trials / Conditions / Hepatotoxicity

Hepatotoxicity

9 registered clinical trials studyying Hepatotoxicity — 3 currently recruiting.

StatusTrialSponsorPhase
Not Yet RecruitingProof-of-concept to Evaluate the Efficacy and Safety of Prednisone in Idiosyncratic Hepatotoxicity
NCT06251232
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y SaludPhase 2
RecruitingUse of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic Leukemia
NCT05501899
Children's Hospital of Orange CountyEARLY_Phase 1
RecruitingA Long-term Study Evaluating Hepatotoxicity Associated With TURALIO™ (Pexidartinib) Treatment
NCT04635111
Daiichi Sankyo—
CompletedMonitoring the HePAtological TOXicity of Drugs (HePATOX)
NCT03833297
Groupe Hospitalier Pitie-Salpetriere—
UnknownAPAP Hepatotoxicity After Therapeutic Doses
NCT03602274
University Hospital, Geneva—
CompletedEffect of Race/Ethnicity and Genes on Acetaminophen Pharmacokinetics
NCT00768716
Tufts UniversityPhase 4
UnknownNAT2 in Re-challenge of INH in Patients With Hepatitis
NCT00728546
National Taiwan University HospitalPhase 4
UnknownNAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatit
NCT02076685
National Taiwan University HospitalN/A
CompletedAcetaminophen-induced Hepatotoxicity in Chronic Alcohol Abusers
NCT00137059
Dr. Marco L.A. SivilottiN/A